Paper41767366
Propolis Supplementation and Metabolic Syndrome Components in Adults at Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Rab SO and 5 others. Health Sci Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Propolis Supplementation and Metabolic Syndrome Components in Adults at Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Papers, record 41767366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41767366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Propolis Supplementation and Metabolic Syndrome Components in Adults at Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34178866 | Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials. | J Diabetes Metab Disord | 2021 | https://conductscience.org/library/papers/34178866 | PubMed |
| 2 | 29241747 | Pathophysiology of the metabolic syndrome. | Clin Dermatol | 2018 | https://conductscience.org/library/papers/29241747 | PubMed |
| 3 | 27187435 | Brazilian Green Propolis Improves Antioxidant Function in Patients with Type 2 Diabetes Mellitus. | Int J Environ Res Public Health | 2016 | https://conductscience.org/library/papers/27187435 | PubMed |
| 4 | 9310563 | Bias in meta-analysis detected by a simple, graphical test. | BMJ | 1997 | https://conductscience.org/library/papers/9310563 | PubMed |
| 5 | 39247130 | The Effects of Propolis Consumption on Body Composition and Blood Pressure: A Systematic Review and Dose-Response Meta-Analysis. | Curr Ther Res Clin Exp | 2024 | https://conductscience.org/library/papers/39247130 | PubMed |
| 6 | 27468795 | Propolis Improves Periodontal Status and Glycemic Control in Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis: A Randomized Clinical Trial. | J Periodontol | 2016 | https://conductscience.org/library/papers/27468795 | PubMed |
| 7 | 34237694 | Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials. | Clin Nutr | 2021 | https://conductscience.org/library/papers/34237694 | PubMed |
| 8 | 34586004 | Abdominal obesity and metabolic syndrome in South Asians: prevention and management. | Expert Rev Endocrinol Metab | 2021 | https://conductscience.org/library/papers/34586004 | PubMed |
| 9 | 39610126 | Effects of propolis consumption on blood pressure, lipid profile and glycemic parameters in adults: a GRADE-assessed systematic review and dose-response meta-analysis. | Br J Nutr | 2025 | https://conductscience.org/library/papers/39610126 | PubMed |
| 10 | 36963888 | Clinical effectiveness of α-lipoic acid, myo-inositol and propolis supplementation on metabolic profiles and liver function in obese patients with NAFLD: A randomized controlled clinical trial. | Clin Nutr ESPEN | 2023 | https://conductscience.org/library/papers/36963888 | PubMed |
| 11 | 16448987 | How to best define the metabolic syndrome. | Ann Med | 2006 | https://conductscience.org/library/papers/16448987 | PubMed |
| 12 | 37337027 | The effects of propolis on pro-oxidant-antioxidant balance, glycemic control, and quality of life in chronic kidney disease: a randomized, double-blind, placebo-controlled trial. | Sci Rep | 2023 | https://conductscience.org/library/papers/37337027 | PubMed |
| 13 | 33166032 | Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial. | Phytother Res | 2021 | https://conductscience.org/library/papers/33166032 | PubMed |
| 14 | 39420195 | Metabolic syndrome. | Nat Rev Dis Primers | 2024 | https://conductscience.org/library/papers/39420195 | PubMed |
| 15 | 29214374 | Serum Antioxidant Parameters are Significantly Increased in Patients with Type 2 Diabetes Mellitus after Consumption of Chinese Propolis: A Randomized Controlled Trial Based on Fasting Serum Glucose Level. | Diabetes Ther | 2018 | https://conductscience.org/library/papers/29214374 | PubMed |
| 16 | 38501085 | Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review. | Front Psychiatry | 2024 | https://conductscience.org/library/papers/38501085 | PubMed |
| 17 | 7786990 | Operating characteristics of a rank correlation test for publication bias. | Biometrics | 1994 | https://conductscience.org/library/papers/7786990 | PubMed |
| 18 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 19 | 37644763 | The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: A double-blind, placebo, controlled randomized clinical trial. | Phytother Res | 2023 | https://conductscience.org/library/papers/37644763 | PubMed |
| 20 | 34208334 | Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review. | Foods | 2021 | https://conductscience.org/library/papers/34208334 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| G6PC1 | 2538 | PubTator's text mining | https://conductscience.org/library/genes/2538 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| LEP | 3952 | PubTator's text mining | https://conductscience.org/library/genes/3952 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 | NCBI Gene |
| PRKAA2 | 5563 | PubTator's text mining | https://conductscience.org/library/genes/5563 | NCBI Gene |
| SLC2A4 | 6517 | PubTator's text mining | https://conductscience.org/library/genes/6517 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41767366
GET https://conductscience.org/api/papers/v1/41767366/references?page=2